What's new

Human medicines European public assessment report (EPAR): Uptravi, selexipag, Date of authorisation: 12/05/2016, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Uptravi, selexipag, Date of authorisation: 12/05/2016, Revision: 17, Status: Authorised

Mar 17, 2025 - 15:42
 0
Human medicines European public assessment report (EPAR): Uptravi, selexipag, Date of authorisation: 12/05/2016, Revision: 17, Status: Authorised
Human medicines European public assessment report (EPAR): Uptravi, selexipag, Date of authorisation: 12/05/2016, Revision: 17, Status: Authorised
Read More

Tags:

Previous Article

These Are The Used Cars You Would Buy With $10,000

Next Article

FERC reaffirms approval of Southeastern SEEM market

Related Posts

Human medicines European public assessment report (EPAR): Galvus, vildagliptin, Date of authorisation: 25/09/2007, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 19, 2025  0

Industry Standing Group

Industry Standing Group

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Xeljanz, tofacitinib, Date of authorisation: 22/03/2017, Date of refusal: 25/04/2013, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 24, 2025  0